Elekta AB (publ) (EKTAY)
Builds radiation therapy machines that treat cancer and brain tumors
$4.96+0.00%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago+3.8%
The outlook
EKTAY trades at 4.96, sitting well below both its 50- and 200-day moving averages, placing it in the lower portion of its 52-week range. Analyst coverage appears thin or unavailable in the data provided. The overall sentiment leans bearish based on current technical positioning.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range24% of the way from its 52-week low to high
Market cap
$1.90B
52-wk high
$6.93
52-wk low
$4.35
50-day avg
$5.38
200-day avg
$5.71
Trailing P/E
—